Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.24 (
mitogen-activated protein kinase
)
95,810
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tumor necrosis factor (TNF) receptor-associated factors (TRAFs) are mediators of many members of the TNF receptor superfamily and can activate both the nuclear factor kappaB (NF-kappaB) and
stress-activated protein kinase
(
SAPK
; also known as
c-Jun N-terminal kinase
) signal transduction pathways. We previously described the involvement of a TRAF-interacting molecule, TRAF-associated NF-kappaB activator (TANK), in TRAF2-mediated NF-kappaB activation. Here we show that TANK synergized with TRAF2, TRAF5, and TRAF6 but not with TRAF3 in
SAPK
activation. TRAF2 and TANK individually formed weak interactions with germinal center kinase (GCK)-related kinase (GCKR). However, when coexpressed, they formed a strong complex with GCKR, thereby providing a potential mechanism for TRAF and TANK synergy in GCKR-mediated
SAPK
activation, which is important in TNF family receptor signaling. Our results also suggest that TANK can form potential intermolecular as well as intramolecular interactions between its amino terminus and carboxyl terminus. This study suggests that TANK is a regulatory molecule controlling the threshold of NF-kappaB and
SAPK
activities in response to activation of TNF receptors. In addition,
CD40
activated endogenous GCKR in primary B cells, implicating GCK family proteins in
CD40
-mediated B-cell functions.
...
PMID:TANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase/stress-activated protein kinase activation through the germinal center kinase pathway. 1049 Jun 5
In human B cells, antigen receptor ligation and
CD40
ligation are known to activate the extracellular-regulated kinases (ERK) and
c-Jun N-terminal kinase
(JNK) pathways, which in turn regulate many important B cell functions. We previously reported that antigen receptor ligation activated the ERK pathway whereas
CD40
ligation activated the JNK/
stress-activated protein kinase
(
SAPK
) pathway. Here, we demonstrate that another
SAPK
, p38/Hog1, is activated by both antigen receptor ligation or
CD40
ligation in a human B-lymphoblastoid cell line and tonsillar B cells. Wortmannin, an inhibitor of phosphatidylinositol 3-kinase, partially inhibited
ERK2
and p38 activation triggered through the B cell receptor whereas activation of JNK1 and p38 through
CD40
was not affected. PD98059, a specific inhibitor of mitogen-activated extracellular response kinase kinase (MEK), significantly inhibited
ERK2
activation and partially inhibited p38 activation triggered by anti-IgM antibody treatment, but did not affect
CD40
-dependent signaling events. In addition, anti-IgM antibody-induced signaling pathways were shown to be PKC-dependent in contrast to the
CD40
-induced signaling pathways. Thus, the B cell receptor and
CD40
recruit the ERK, JNK and p38 pathways by using different upstream effectors.
...
PMID:Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor and CD40 in human B cells. 1050 74
We investigated whether human monocyte-derived dendritic cells (DCs) differed from tonsillar B cells in the set of cell fate genes they express constitutively and in the way these genes are affected after
CD40
ligation. In particular, Bcl-2, TNF receptor-associated factor-2 (TRAF2), and TRAF4 were clearly inducible via
CD40
in B cells but not in DCs. DCs, unlike B cells, were induced to increase expression of IL-1beta, IL-1Ra, IL-8, IL-12 p40, RANTES, macrophage inflammatory protein-1alpha, and monocyte chemoattractant protein-1 after
CD40
ligation. We next tested whether
CD40
-induced signaling pathways were different in DCs vs B cells. In DCs, as in B cells,
CD40
ligation activated p38 mitogen-activated protein kinase (
MAPK
), its downstream target, MAPKAPK-2, and the
c-Jun N-terminal kinase
. The p38
MAPK
-specific inhibitor, SB203580, blocked
CD40
-induced MAPKAPK-2 activation, but did not affect activation of
c-Jun N-terminal kinase
. Furthermore, unlike in B cells,
extracellular signal-regulated kinase
-1 and -2 were activated after
CD40
ligation in DCs. SB203580 strongly blocked
CD40
-induced IL-12 p40 production in DCs at both mRNA and protein levels, while having minimal effect on
CD40
-induced expression of the chemokine RANTES. In contrast, no detectable IL-12 p40 protein was secreted in
CD40
-stimulated B cells. Furthermore,
CD40
-induced mRNA expression of cellular inhibitor of apoptosis protein-2 was also dependent on the p38
MAPK
pathway in DCs and differed compared with that in B cells. In conclusion,
CD40
induces distinct programs in DCs and B cells, and the set of p38
MAPK
-dependent genes in DCs (IL-12 p40 and cellular inhibitor of apoptosis protein-2) is different from that in B cells (IL-10 and IL-1beta).
...
PMID:Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. 1057 Feb 61
We and others previously observed that IgM and
CD40
stimulation in murine B cells resulted in activation of
extracellular signal-regulated kinase
(
ERK
), a subfamily of
mitogen-activated protein kinase
. The present study demonstrated that
ERK
was rapidly phosphorylated and translocated to the nucleus in murine B cells upon stimulation with
CD40
, whereas it was preferentially localized within the cytosol after stimulation with IgM, suggesting that signaling through
CD40
and IgM differentially regulates
ERK
subcellular localization. Costimulation with
CD40
and IgM (
CD40
/IgM) resulted in subcellular localization of
ERK
within the cytosol, supporting the notion that stimulation with IgM delivers the signal responsible for inhibition of
ERK
nuclear transport. Consistent with these observations, IgM and
CD40
/IgM stimulation resulted in activation of ribosomal S6 kinase, which is a cytoplasmic substrate for
ERK
, whereas
CD40
stimulation had little effect on its activity. Disruption of the microtubule by colchicine in WEHI231 cells resulted in reduction of
ERK
activity in IgM signaling, but not in
CD40
signaling, compatible with the notion that the microtubule network may hold cytoplasmic
ERK
activity mediated by IgM stimulation. These results support the notion that
ERK
could mediate different effector functions in B cells upon stimulation with IgM and
CD40
.
...
PMID:Distinct subcellular localization and substrate specificity of extracellular signal-regulated kinase in B cells upon stimulation with IgM and CD40. 1058 53
Recently, it has been demonstrated that the
CD40
receptor is constitutively expressed on cultured microglia at low levels. Ligation of
CD40
by CD40 ligand on these cells results in microglial activation, as measured by TNF-alpha production and neuronal injury. However, the intracellular events mediating this effect have yet to be investigated. We report that ligation of microglial
CD40
triggers activation of p44/42
mitogen-activated protein kinase
(
MAPK
). This effect is evident 30 min posttreatment, and progressively declines thereafter (from 30 to 240 min). Phosphorylated p38
MAPK
is not observed in response to ligation of microglial
CD40
across the time course examined. Inhibition of the upstream activator of p44/42
MAPK
, mitogen-activated protein/extracellular signal-related kinase kinase 1/2, with PD98059, decreases phosphorylation of p44/42
MAPK
and significantly reduces TNF-alpha release following ligation of microglial
CD40
. Furthermore, cotreatment of microglial cells with CD40 ligand and TGF-beta1 or IL-10, or both, inhibits
CD40
-mediated activation of p44/42
MAPK
and production of TNF-alpha in a statistically interactive manner. Taken together, these data show that ligation of microglial
CD40
triggers TNF-alpha release through the p44/42
MAPK
pathway, an effect that can be opposed by TGF-beta1 and IL-10.
...
PMID:Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. 1058 56
The vertebrate immune system recognizes bacterial DNA based on the presence of unmethylated CpG-dinucleotides in particular base contexts ("CpG motifs"). In contrast to mice, knowledge about CpG-mediated effects on human B cells is poor. In the present study we identify and determine an optimal human CpG motif. A phosphodiester oligonucleotide containing this motif strongly stimulated CD86,
CD40
, CD54, and MHC class II expression, IL-6 synthesis, and proliferation of primary human B cells. These effects required internalization of the oligonucleotide and endosomal maturation. The molecular mechanism of action of this CpG motif was associated with the sustained induction of the NF-kappaB p50/p65 heterodimer and of the transcription-factor complex AP-1. Transcription-factor activation by CpG DNA was preceded by increased phosphorylation of the stress kinases
c-Jun N-terminal kinase
and p38, and of activating transcription factor-2. In contrast to CpG, signaling through the B cell receptor led to activation of extracellular receptor kinase and to phosphorylation of a different isoform of
c-Jun N-terminal kinase
. These studies define the structure of a highly active human CpG motif and characterize its molecular mechanism of action in primary human B cells.
...
PMID:Mechanism and function of a newly identified CpG DNA motif in human primary B cells. 1062 43
Signals delivered to antigen-presenting cells through
CD40
are critical for the activation of immune responses. Intracellular tumor necrosis factor (TNF) receptor-associated factors (TRAFs) are key elements of the signal transduction pathways of many TNF receptor family members, including
CD40
. We show for the first time that engagement of
CD40
in intact B cells induces the rapid translocation of TRAF2 from the cytoplasm to the plasma membrane. We found that
CD40
engagement also results in its recruitment, together with TRAF2 and TRAF3, to membrane microdomains, regions of the plasma membrane enriched in signaling molecules such as the Src family kinases. Using a membrane-permeable chelator of zinc or a mutant TRAF2 molecule, we show that the putative zinc-binding domains of TRAFs contribute to their recruitment to microdomains and to the downstream activation of
c-Jun N-terminal kinase
. We suggest that the zinc RING and zinc finger domains of TRAFs are required for communication between
CD40
and microdomain-associated signaling molecules and may serve a similar role in the signal transduction pathways of other TNF receptor family members.
...
PMID:Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. 1074 39
As a dendritic cell (DC) matures, it becomes more potent as an antigen-presenting cell. This functional change is accompanied by a change in DC immunophenotype. The signal transduction events underlying this process are poorly characterized. In this study, we have investigated the signal transduction pathways involved in the lipopolysaccharide (LPS)-induced maturation of human monocyte-derived DCs (MoDCs) in vitro. We show that exposure of immature MoDCs to LPS activates the p38
stress-activated protein kinase
(p38SAPK), extracellular signal-regulated protein kinase (ERK), phosphoinositide 3-OH kinase (PI3 kinase)/Akt, and nuclear factor (NF)-kappaB pathways. Studies using inhibitors demonstrate that PI3 kinase/Akt but not the other pathways are important in maintaining survival of LPS-stimulated MoDCs. Inhibiting p38SAPK prevented activation of the transcription factors ATF-2 and CREB and significantly reduced the LPS-induced up-regulation of CD80, CD83, and CD86, but did not have any significant effect on the LPS-induced changes in macropinocytosis or HLA-DR,
CD40
, and CD1a expression. Inhibiting the NF-kappaB pathway significantly reduced the LPS-induced up-regulation of HLA-DR as well as CD80, CD83, and CD86. Inhibiting the p38SAPK and NF-kappaB pathways simultaneously had variable effects depending on the cell surface marker studied. It thus appears that different aspects of LPS-induced MoDC maturation are regulated by different and sometimes overlapping pathways.
...
PMID:The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. 1091 Sep 20
It has been reported that ligation of
CD40
with CD40 ligand (CD40L) results in microglial activation as evidenced by p44/42
mitogen-activated protein kinase
(
MAPK
) dependent tumor necrosis factor alpha (TNF-alpha) production. Previous studies have shown that CD45, a functional transmembrane protein-tyrosine phosphatase, is constitutively expressed at moderate levels on microglial cells and this expression is greatly elevated on activated microglia. To investigate the possibility that CD45 might modulate CD40L-induced microglial activation, we treated primary cultured microglial cells with CD40L and anti-CD45 antibody. Data show that cross-linking of CD45 markedly inhibits CD40L-induced activity of the Src family kinases Lck and Lyn. Further, co-treatment of microglia with CD40L and anti-CD45 antibody results in significant inhibition of microglial TNF-alpha production through inhibition of p44/42
MAPK
activity, a downstream signaling event resulting from Src activation. Accordingly, primary cultured microglial cells from mice deficient in CD45 demonstrate hyper-responsiveness to ligation of
CD40
, as evidenced by increased p44/42
MAPK
activation and TNF-alpha production. Taken together, these results show that CD45 plays a novel role in suppressing CD40L-induced microglial activation via negative regulation of the Src/p44/42
MAPK
cascade.
...
PMID:CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. 1097 11
Platelet activation and adhesion to endothelial cells and extracellular matrix proteins are crucial events in the development of arterial cardiovascular diseases. Platelet activation is initiated by stimulation of intracellular signaling cascades, including the
p42 mitogen-activated protein kinase
(
MAPK
) and p38
MAPK
pathways, followed by major changes in the platelet cytoskeleton and expression and activation of platelet surface receptors, such as P-selectin (CD62P) and CD40 ligand (CD40L). Activated platelets directly bind to vascular endothelial cells via CD40L/
CD40
interactions and induce inflammatory reactions that initiate or aggravate atherosclerotic lesions. The aim of this study was to investigate effects of two known platelet inhibitors-the cAMP-elevating prostaglandin E(1) (PG-E(1)) and the cGMP-elevating sodium nitroprusside (SNP)-on platelet p42
MAPK
and p38
MAPK
activation as well as on surface expression of CD62P and CD40L.
MAPK
activation was analyzed by Western blot experiments using phosphorylation-specific antibodies, and surface CD40L and CD62P expression was determined by flow cytometry analysis. PG-E(1) and SNP strongly inhibited p42 and p38
MAPK
phosphorylation as well as CD40L and CD62P expression in response to thrombin, a thromboxane A(2) analog, and ADP. These data indicate that adenosine and guanosine 3',5'-cyclic monophosphate-dependent protein kinases not only inhibit platelet pathways leading to activation and aggregation, but also those resulting in enhanced surface expression of protein ligands involved in inflammation. Expression of CD40L and CD62P was found to be independent of
MAPK
activation, since it was not inhibited by specific
MAPK
inhibitors. Inhibition of platelet-induced inflammatory responses including CD62P- and CD40L-mediated interaction of platelets with leukocytes and endothelial cells, respectively, is suggested to be an important component of the long-term vasoprotective effects of cyclic nucleotide-elevating prostaglandins and NO donors.
...
PMID:Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets. 1100 34
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>